SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

LB Pharmaceuticals appoints Joseph Miller as chief financial officer

LB Pharmaceuticals Inc said it appointed Joseph Miller as its chief financial officer. The neuromedicines company focuses on developing and commercializing therapies for underserved brain disorders.

LBRX

NEW YORK, Sept.

03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) NASDAQ:LBRX, a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced th…